Composition
- Active ingredients
- TRIMETREXATE GLUCURONATE EQ 200MG BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TRIMETREXATE GLUCURONATE EQ 200MG BASE/VIAL · InjectableThis page
- TRIMETREXATE GLUCURONATE EQ 25MG BASE/VIAL · InjectableNDA020326-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020326.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Neutrexin
- Active substance
- trimetrexate glucuronate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Medimmune Oncology
- Status
- Discontinued
- FDA approval
- 17 Dec 1993
- Application
- NDA020326-002